All In MedTech

Device Trial Radar · NCT01927172

AirSonea Wheeze Detection Study

AirSonea Wheeze Detection Study - Multipart Clinical Performance Assessment to Determine Agreement on Wheeze Detection Between AirSonea™ Versus Physician Auscultation and an Expert Panel.

Last checked: Nov 19, 2026Latest source record: Aug 22, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

85

Planned (sponsor's estimate)

Start

Sep 2013

Primary completion

Aug 2014

Sponsor

Lead sponsor
iSoneaNot on our public-company list
Sponsor type
Industry
First posted
Aug 22, 2013

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Single group
Masking
Single (investigator)
Primary purpose
Diagnostic
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine if the AirSonea device provides an objective assessment of breath sounds for the presence of wheeze in both medical and home environments.

Conditions

  • COPD
  • Asthma

Interventions

  • AirSoneaDevice

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Device EfficacyTime frame: 1 day

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.